Myeloproliferative neoplasm risk factors: Difference between revisions
Jump to navigation
Jump to search
Shyam Patel (talk | contribs) No edit summary |
Shyam Patel (talk | contribs) |
||
| Line 7: | Line 7: | ||
*'''Age''': Age is a major risk factor for the development of myeloproliferative neoplasm. Aging is associated with the acquisition of mutations in cells, and these mutations can lead to the development of hematologic malignancies. | *'''Age''': Age is a major risk factor for the development of myeloproliferative neoplasm. Aging is associated with the acquisition of mutations in cells, and these mutations can lead to the development of hematologic malignancies. | ||
*'''Autoimmunity''': A prior history of autoimmune disease is associated with a risk for developing myeloproliferative neoplasms.<ref name="pmid20053870">{{cite journal| author=Kristinsson SY, Landgren O, Samuelsson J, Björkholm M, Goldin LR| title=Autoimmunity and the risk of myeloproliferative neoplasms. | journal=Haematologica | year= 2010 | volume= 95 | issue= 7 | pages= 1216-20 | pmid=20053870 | doi=10.3324/haematol.2009.020412 | pmc=2895049 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20053870 }} </ref> There is specifically an increased risk of myeloproliferative neoplasm is patients with: | *'''Autoimmunity''': A prior history of autoimmune disease is associated with a risk for developing myeloproliferative neoplasms.<ref name="pmid20053870">{{cite journal| author=Kristinsson SY, Landgren O, Samuelsson J, Björkholm M, Goldin LR| title=Autoimmunity and the risk of myeloproliferative neoplasms. | journal=Haematologica | year= 2010 | volume= 95 | issue= 7 | pages= 1216-20 | pmid=20053870 | doi=10.3324/haematol.2009.020412 | pmc=2895049 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20053870 }} </ref> The etiology for the link between autoimmunity and myeloproliferative neoplasm is thought to be antigenic stimulation which results in immune cell activation and aberrant proliferation. There is specifically an increased risk of myeloproliferative neoplasm is patients with: | ||
**[[Crohn's disease]]: This carries a 2.9-fold increased risk. | **[[Crohn's disease]]: This carries a 2.9-fold increased risk. | ||
**[[Immune thrombocytopenia purpura]]: This carries a 1.8-fold increased risk. | **[[Immune thrombocytopenia purpura]]: This carries a 1.8-fold increased risk. | ||
Revision as of 18:34, 19 June 2018
|
Myeloproliferative Neoplasm Microchapters |
|
Differentiating myeloproliferative neoplasm from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Myeloproliferative neoplasm risk factors On the Web |
|
American Roentgen Ray Society Images of Myeloproliferative neoplasm risk factors |
|
Directions to Hospitals Treating Myeloproliferative neoplasm |
|
Risk calculators and risk factors for Myeloproliferative neoplasm risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2] Shyam Patel [3]
Overview
There are no established risk factors for myeloproliferative neoplasm.
Risk factors
- Age: Age is a major risk factor for the development of myeloproliferative neoplasm. Aging is associated with the acquisition of mutations in cells, and these mutations can lead to the development of hematologic malignancies.
- Autoimmunity: A prior history of autoimmune disease is associated with a risk for developing myeloproliferative neoplasms.[1] The etiology for the link between autoimmunity and myeloproliferative neoplasm is thought to be antigenic stimulation which results in immune cell activation and aberrant proliferation. There is specifically an increased risk of myeloproliferative neoplasm is patients with:
- Crohn's disease: This carries a 2.9-fold increased risk.
- Immune thrombocytopenia purpura: This carries a 1.8-fold increased risk.
- Polymyalgia rheumatica: This carries a 1.7-fold increased risk.
- Giant cell arteritis: This carries a 5.9-fold increased risk.
- Reiter's reactive arthritis: This carries a 15.9-fold increased risk.
- Aplastic anemia: This carries a 7.8-fold increased risk.
References
- ↑ Kristinsson SY, Landgren O, Samuelsson J, Björkholm M, Goldin LR (2010). "Autoimmunity and the risk of myeloproliferative neoplasms". Haematologica. 95 (7): 1216–20. doi:10.3324/haematol.2009.020412. PMC 2895049. PMID 20053870.